[gtranslate]

Eli Lilly (NYSE: LLY) trades at roughly $1,029 per share as of February 2026. The stock hit an all-time closing high of $1,108 in November 2025. Over the past five years, LLY has returned over 400% to shareholders.

Stock Price of Eli Lilly

Eli Lilly Stock Forecast

Wall Street analysts give Eli Lilly a consensus "Strong Buy" rating. Based on 42 analysts tracked by TickerNerd, the median 12-month price target is $1,145, with estimates ranging from $770 to $1,500. The bullish case rests on continued growth of Mounjaro and Zepbound, plus pipeline catalysts in Alzheimer's and oncology. The bear case centers on potential pricing pressure from GLP-1 competitors and manufacturing bottlenecks. Analysts project EPS could reach $46 by 2030, supporting a price target near $1,759 according to 24/7 Wall St. estimates.

Eli Lilly Valuation

Timeline of Eli Lilly Funding

1876
Colonel Eli Lilly self-funds the company with personal capital, opening a lab in Indianapolis with three employees.
1890
Incorporated as Eli Lilly and Company. Josiah K. Lilly Sr. and other family members invest additional private capital to expand operations.
Jan 1952
Eli Lilly lists on the New York Stock Exchange under ticker LLY, opening public equity markets for the first time.
1968
The Lilly Endowment, established in 1937 by founding family members, is reorganized as a 501(c)(3). It remains a top-ten stakeholder today.
2020–2025
Eli Lilly issues multiple debt offerings to fund over $50 billion in manufacturing expansion for GLP-1 drugs and pipeline compounds.
Nov 2025
Market cap hits $1 trillion, the first healthcare company in history to reach that milestone.

Eli Lilly Investors

Lilly Endowment Inc.
Shares 92.20M
Ownership ~9.75%
Type Charitable Foundation
Est. Value ~$93.1B
The Vanguard Group
Shares ~74.5M
Ownership ~7.9%
Type Asset Manager
Est. Value ~$76.7B
Shares ~62.8M
Ownership ~6.6%
Type Asset Manager
Est. Value ~$64.6B
State Street Corp
Shares ~40.2M
Ownership ~4.3%
Type Asset Manager
Est. Value ~$41.4B
PNC Financial Services
Shares ~60.5M
Ownership ~6.4%
Type Financial Holding Co.
Est. Value ~$62.3B
Capital Research & Mgmt
Shares ~25.0M
Ownership ~2.6%
Type Active Fund Manager
Est. Value ~$25.7B